# Fortress Biotech, Inc.: Form SCHEDULE 13D/A, filed Mar 20, 2026

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 16:16 ET
- Period: not reported
- Accession: 0001104659-26-032728
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000110465926032728/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000110465926032728/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000110465926032728/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-032728. Last ingested by Listed: Oct 29, 2026, 17:38 ET. No prices; not investment advice.